Comparison 14. Ankaferd Blood Stopper (ABS) versus Ferric Sulfate (FS) pulpotomy.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Clinical failure	2		Risk Ratio (M‐H, Fixed, 95% CI)	Subtotals only
1.1 6 months	2	100	Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
1.2 12 months	2	100	Risk Ratio (M‐H, Fixed, 95% CI)	1.25 [0.37, 4.27]
2 Radiological failure	2		Risk Ratio (M‐H, Fixed, 95% CI)	Subtotals only
2.1 6 months	2	100	Risk Ratio (M‐H, Fixed, 95% CI)	1.0 [0.16, 6.20]
2.2 12 months	2	100	Risk Ratio (M‐H, Fixed, 95% CI)	0.88 [0.34, 2.23]
3 Pain	2		Risk Ratio (M‐H, Fixed, 95% CI)	Subtotals only
3.1 6 months	2	100	Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
3.2 12 months	2	100	Risk Ratio (M‐H, Fixed, 95% CI)	1.0 [0.15, 6.71]
4 Soft tissue pathology	2		Risk Ratio (M‐H, Fixed, 95% CI)	Subtotals only
4.1 6 months	2	100	Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
4.2 12 months	2	100	Risk Ratio (M‐H, Fixed, 95% CI)	1.5 [0.27, 8.43]
5 Pathologic mobility	2		Risk Ratio (M‐H, Fixed, 95% CI)	Subtotals only
5.1 6 months	2	100	Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
5.2 12 months	2	100	Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
6 Pathologic radiolucency	2		Risk Ratio (M‐H, Fixed, 95% CI)	Subtotals only
6.1 6 months	2	100	Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
6.2 12 months	2	100	Risk Ratio (M‐H, Fixed, 95% CI)	0.67 [0.12, 3.75]
7 Pathologic root resorption	2		Risk Ratio (M‐H, Fixed, 95% CI)	Subtotals only
7.1 6 months	2	100	Risk Ratio (M‐H, Fixed, 95% CI)	5.0 [0.26, 96.13]
7.2 12 months	2	100	Risk Ratio (M‐H, Fixed, 95% CI)	1.0 [0.31, 3.23]